Deals Of The Week: Evolva/Arpida; Genzyme/Targeted Genetics; Biotechnol/Digna Biotech/Genentech
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
Having twice said no and adopting a poison pill plan, the former R&D shop at PDL will stay independent--for now.
Reverse mergers are an increasingly common fundraising strategy for biotech. But do they pay off?
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011